ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood transplant offers hope for blood cancer patients
Disease control Recruiting nowThis study uses a cord blood transplant after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. About 200 participants will receive the transplant to see if it improves survival one year later. The approach aims to replace diseased bone …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cell therapy aims to stop High-Risk leukemia in its tracks
Disease control Recruiting nowThis study tests a cell therapy called obecabtagene autoleucel (obe-cel) in 30 adults with a high-risk type of leukemia (B-cell ALL) that is in remission after initial treatment. The goal is to see if obe-cel can help keep the cancer from coming back. Participants receive the the…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC